Literature DB >> 12496252

Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex.

Zhengfan Jiang1, H Jan Johnson, Huiqing Nie, Jinzhong Qin, Timothy A Bird, Xiaoxia Li.   

Abstract

The signaling pathway downstream of the mammalian interleukin-1 receptor (IL-1R)/Toll-like receptor (TLR) is evolutionally conserved with that mediated by the Drosophila Toll protein. Toll initiates its signal through the adapter molecule Tube and the serine-threonine kinase Pelle. Pelle is highly homologous to members of the IL-1R-associated kinase (IRAK) family in mammals. Recently, a novel Pelle-interacting protein called Pellino was identified in Drosophila. We now report a mammalian counterpart of Pellino, termed Pellino 1, which is required for NF kappa B activation and IL-8 gene expression in response to IL-1, probably through its signal-dependent interaction with IRAK4, IRAK, and the tumor necrosis factor receptor-associated factor 6 (TRAF6). The Pellino 1-IRAK-IRAK4-TRAF6 signaling complex is likely to be intermediate, located between the IL-1 receptor complex and the TAK1 complex in the IL-1 pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12496252     DOI: 10.1074/jbc.M212112200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Pellino 2 is critical for Toll-like receptor/interleukin-1 receptor (TLR/IL-1R)-mediated post-transcriptional control.

Authors:  Tae Whan Kim; Minjia Yu; Hao Zhou; Wei Cui; Jianan Wang; Paul DiCorleto; Paul Fox; Hui Xiao; Xiaoxia Li
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance.

Authors:  Wei Jin; Mikyoung Chang; Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

3.  Pellino-3 promotes endotoxin tolerance and acts as a negative regulator of TLR2 and TLR4 signaling.

Authors:  Michael B Murphy; Yanbao Xiong; Goutham Pattabiraman; Tissa T Manavalan; Fu Qiu; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2015-08-26       Impact factor: 4.962

4.  IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells.

Authors:  Donald J Davidson; Andrew J Currie; Dawn M E Bowdish; Kelly L Brown; Carrie M Rosenberger; Rebecca C Ma; Johan Bylund; Paul A Campsall; Anne Puel; Capucine Picard; Jean-Laurent Casanova; Stuart E Turvey; Robert E W Hancock; Rebecca S Devon; David P Speert
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 5.  Scaffold proteins and immune-cell signalling.

Authors:  Andrey S Shaw; Erin L Filbert
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

6.  Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20.

Authors:  Yanbao Xiong; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

7.  Pellino-1 Protects Periodontal Ligament Stem Cells Against H2O2-Induced Apoptosis via Activation of NF-κB Signaling.

Authors:  Jiangang Tian; Liufang Gu; Andrew Adams; Xueliang Wang; Ruizhe Huang
Journal:  Mol Biotechnol       Date:  2018-08       Impact factor: 2.695

8.  Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway.

Authors:  Sunil K Manna; Govindarajan T Ramesh
Journal:  J Biol Chem       Date:  2004-12-09       Impact factor: 5.157

Review 9.  Tyrosine phosphorylation in Toll-like receptor signaling.

Authors:  Saurabh Chattopadhyay; Ganes C Sen
Journal:  Cytokine Growth Factor Rev       Date:  2014-06-21       Impact factor: 7.638

10.  Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production.

Authors:  Mikyoung Chang; Wei Jin; Shao-Cong Sun
Journal:  Nat Immunol       Date:  2009-09-06       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.